Target intelligence / Profile preview

Rho GTPase activating protein 23 pseudogene 1 (ARHGAP23P1)

Target
ARHGAP23P1
Molecular classification
Other
01

Overview

Rho GTPase activating protein 23 pseudogene 1 (ARHGAP23P1) is a human pseudogene, meaning it is a DNA sequence similar to a functional gene (in this case, ARHGAP23), but it does not encode a functional protein due to mutations or lack of appropriate regulatory elements. ARHGAP23P1 does not produce an active protein and has no known direct biological function or disease association. It is not considered a therapeutic target, receptor, enzyme, or signaling protein. The canonical gene, ARHGAP23, is a member of the RhoGAP family and regulates Rho GTPases which are involved in numerous cellular functions, but ARHGAP23P1 is distinguished as a noncoding pseudogene[4]. Notes: - ARHGAP23P1 is specifically annotated as a pseudogene and not as a protein-coding gene or functional target[4]. - There is nothing to indicate it plays a direct role in signaling, as a receptor, or in human disease biology; therefore, it cannot be considered a drug target, and no drugs, mechanisms of action, or safety concerns are applicable. - No evidence suggests ARHGAP23P1 is used as a biomarker. - The entry is considered not suitable as a druggable target or receptor nomenclature. - If you are referencing the functional Rho GTPase-activating protein 23, the target would be ARHGAP23 rather than ARHGAP23P1.

Other names
ARHGAP23P1

Beyond the preview

Go deeper on Rho GTPase activating protein 23 pseudogene 1 (ARHGAP23P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rho GTPase activating protein 23 pseudogene 1 (ARHGAP23P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call